Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
96.00    -1.50 (-1.54%)
Bid:
94.00
Ask:
98.00
Spread: 4.00 (4.255%)
Market Cap: £111.67m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Proposed Long Term Incentive Plan

1 Jun 2026 07:00

RNS Number : 3760G
Brave Bison Group PLC
01 June 2026
Β 

1 June 2026

Β 

Brave Bison Group plc

Β 

("Brave Bison" or the "Company", together with its subsidiaries "the Group")Β 

Β 

2026 Long Term Incentive Plan

Β 

Β 

Further to the Company's announcement of 18 May 2026 and publication of notice of the Company's annual general meeting to be held on 17 June 2026 (the "AGM"), the Company announces the terms of the proposed 2026 Brave Bison Long Term Incentive Plan (the "LTIP").

Β 

In finalising the terms of the LTIP, the Company's Remuneration Committee has conducted a consultation with shareholders representing approximately 70% of the Company's issued ordinary share capital, including the directors and related parties. The proposed terms of the LTIP reflect the outcome of that consultation, including revisions made in response to feedback received.

Β 

Remuneration Philosophy

Β 

Brave Bison is a growth company pursuing an acquisition-led strategy in fragmented digital media, marketing and technology markets. The Remuneration Committee believes that executive remuneration should be structured to create direct and transparent alignment between executive reward and long-term shareholder value creation.

Β 

The Remuneration Committee's philosophy rests on three principles. First, executives should only be materially rewarded when shareholders have first seen substantial appreciation in the value of their investment. Second, the cost of the plan to shareholders should arise as a consequence of value having been created - with an LTIP that is self-funding by design. Third, the incentive structure should support long-term decision-making consistent with a growth and acquisition-led strategy, rather than incentivising short-term earnings management.

Β 

The previously adopted 2021 LTIP delivered total shareholder returns of 176% over its life, representing a compound annual growth rate of approximately 31%. The Remuneration Committee believes the value creation plan structure was instrumental in driving this outcome and that a continuation of this approach, with appropriately recalibrated terms reflecting the Company's larger equity base, is in the best interests of all shareholders.

Β 

Β 

Structure and Key Terms

Β 

The proposed LTIP is a value creation plan. The essence of the LTIP is that, subject to a minimum share price hurdle of 150p, the Executives may earn up 12% of value created for shareholders above an annual indexation of 8% per annum and subject to limits and caps specified below.

Β 

The principal terms are as follows:

Β 

Β§ Oliver Green and Theodore Green will the sole participants, on a 50:50 basis;

Β 

Β§ each Executive shall subscribe for awards comprising non-voting subordinate shares in a wholly owned subsidiary of the Company ("B Shares");

Β 

Β§ the baseline share price is 80p, being the price of an ordinary share in the Company (an "Ordinary Share") at the time of the 2021 LTIP redemption in September 2025;

Β 

Β§ the minimum exercise price i.e. the price of an Ordinary Share which must be reached before the Executives can elect to redeem their B Shares, is 150p - a hard hurdle representing an 88% increase from the baseline price. The LTIP will deliver no value to the Executives at any share price below 150p;

Β 

Β§ the Executives will receive a 12% share of value created above the baseline price, subject at all times to the annual indexation and minimum exercise price hurdle;

Β 

Β§ the baseline value of shares to be acquired under the LTIP is subject to annual indexation of 8% per annum for the duration of the LTIP. This means the effective hurdle against which executive value is measured increases each year, ensuring that the minimum threshold for reward keeps pace with a reasonable cost of capital and that Executives are not rewarded merely for the passage of time. In the event of further equity issuances during the plan period, the value of that new equity is subject to the same 8% indexation from the point of issuance, on the same basis as the existing equity;

Β 

Β§ the underlying performance conditions will subsist for a minimum of three years commencing with effect from 1 January 2026. Subject to attainment of the required hurdles by 31 December 2028 (or such longer period as the Remuneration Committee may, in its absolute discretion, determine), the Executives may redeem their awards at any point during the period from 1 January 2029 to 31 December 2031; and

Β 

Β§ the exercise price is calculated by reference to the 90-day volume-weighted average price ("VWAP") at the point of redemption. This provides a robust measure of sustained value creation.

Β 

Upon adoption of the LTIP, the Executives shall subscribe for the B Shares.Β Subject to the achievement of performance conditions under the LTIP (as outlined above), the B Shares can be redeemed by the Executives in exchange for new Ordinary Shares.

B Shares will be capable of redemption by the Executives with an aggregate value equal toΒ 12% of value created for the Company's shareholders from the adoption of the LTIP to redemption(s) of the B Shares, calculated as:Β 

a. the market value of all Ordinary Shares in issue on redemption of B Shares, lessΒ 

b. the market value of theΒ 112.3 millionΒ Ordinary Shares currently in issue on redemption based on an opening share price ofΒ 80Β pence per Ordinary Share, indexed at a compounding annualised growth rate ofΒ 8%, lessΒ 

Β 

c. the issue value of anyΒ additionalΒ new Ordinary Shares issued following adoption of the LTIP and prior to redemption(s) of the B Shares, indexed at a compounding annualised growth rate ofΒ 8%, plusΒ 

Β 

d. the value of any dividends, share buy backs or any other distributions to shareholders following the implementation of the LTIP and prior to the redemption(s) of the B Shares,

(the "Redemption Value").Β 

In calculating the number of new Ordinary Shares to be issued to the Executives on redemption(s), the Redemption Value will be divided by the 90-dayΒ VWAP, subject to the total number of Ordinary Shares capable of issue under the LTIP in no circumstances exceedingΒ 6% of the Company's issued ordinary share capital.Β The Redemption Value is capped at Β£15 million per Executive.

Β 

Furthermore, redemption(s) of the B Shares will be restricted such that the aggregate holding of Ordinary Shares by the Executives and their connected persons does not exceed 29.9% of the Company's share capital.Β 

The B Shares will also become eligible for redemptionΒ in the event ofΒ the sale of the Company, the sale of more than 51% of the Company to an unconnected party or the winding up of the Company.Β In the event of a change of control of the Company occurring before 31 December 2026, only 50% of any awards will be redeemable and 50% will lapse. This provides a safeguard for shareholders in respect of the cost of the plan against early monetisation.

Any new Ordinary Shares issued pursuant to a redemption of B Shares under the LTIP are required to be held for a minimum period ofΒ 12 months, with a carve out for settling tax liabilities due on redemption. Awards under the LTIP are also subject to customary malus provisions in-line with best practice.

Β 

Employee EMI share options (excluding options granted through acquisitions), including anticipated near-term awards total 4.95 million shares, representing 4.4% of current issued share capital. The combined potential dilution from all employee incentive arrangements therefore remains within parameters appropriate for a growth company of Brave Bison's profile.

Β 

Illustrative Outcomes

Β 

The table below sets out illustrative outcomes at a range of share prices, based on 112.3 million shares in issue as at the end of April 2026 and with no changes in shares in issue during the period

Β 

Exercise Price

Β 

145p

150p

175p

200p

217p

Absolute increase from 80p

81%

88%

119%

150%

171%

Number of shares at end

m

112.3

112.3

112.3

112.3

112.3

Equity value at end

Β£m

162.8

168.4

196.5

224.6

243.7

Value created for shareholders

Β£m

73.0

78.6

106.7

134.7

153.8

Redemption Value

Β£m

Β -

6.6

10.0

13.4

15.7

Value per executive

Β£m

Β -

3.3

5.0

6.7

7.8

Total shares issued for executives (m)

m

Β -

4.4

5.7

6.7

7.2

Dilution to shareholders

0.0%

3.8%

4.8%

5.6%

6.0%

Β 

The plan delivers no value to the Executives at a share price below 150p. At the 150p threshold, shareholders would have seen 88% appreciation from the baseline price before any value reaches the executives. In the scenario presented above, the dilution cap of 6% would come into effect from an exercise price of 217p.

Β 

Related Party Transaction and Shareholder Vote

Β 

The Remuneration Committee has conducted a thorough consultation with shareholders and has made substantial revisions to the terms of the plan in response to feedback received. The Remuneration Committee believes the plan as now proposed appropriately balances the need to retain and incentivise the executive team that has delivered strong results for shareholders, while incorporating meaningful protections against dilution and short-term reward.

Β 

The LTIP is deemed to constitute a related party transaction for the purposes of AIM Rule 13. The Company's independent Directors (being all directors excluding Oliver and Theo Green) consider that the terms of the LTIP are fair and reasonable insofar as its Shareholders are concerned.

Β 

Shareholders are invited to express support for the LTIP by voting in favour of Resolution 14 in an advisory vote at the AGM.

Β 

For further information please contact:β€―Β 

β€―Β 

Brave Bison Group plc via CavendishΒ 

Oliver Green, Executive Chairman Β 

Theo Green, Chief Growth Officerβ€―Β 

Philippa Norridge, Chief Financial Officerβ€―Β 

β€―Β 

Cavendish Capital Markets Tel: +44 (0) 20 7220 0500Β 

Nominated Adviser & Joint Brokerβ€―Β 

Ben Jeynesβ€―/ Teddy Whiley - Corporate FinanceΒ 

Michael Johnson / Sunila de Silva - ECM

Β 

Singer Capital Markets Tel: +44 (0) 20 7496 3000Β 

Joint BrokerΒ Β 

Paul Richards

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCAKDBQKBKBDPN
Date   Source Headline
19th Jun 20264:26 pmRNSHolding(s) in Company
17th Jun 20264:41 pmRNSResult of Annual General Meeting
17th Jun 20267:00 amRNSAGM Statement
15th Jun 20267:00 amRNSMark Ritson Option Exercise
8th Jun 20265:17 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.